Found 24 matching trials
Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial N/A The primary purpose of this study is to determine whether the hepatitis C v...
Show More Learn More & Join Trial
Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis PHASE2 Background:
Chronic hepatitis D is a serious liver disease caused by a vir...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection PHASE2 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon PHASE2 Background:
Infection with hepatitis D virus leads to a chronic liver dise...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C PHASE3 The purpose of this study is to determine if 48 weeks of therapy with Pegyl...
Show More Location
Local Institution
Learn More & Join Trial
Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction PHASE1 The purpose of this study is to determine the effect of renal impairment on...
Show More Location
Clinical Pharmacology Of Miami Inc.
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 PHASE3 The purpose of this study is to determine if 24 weeks of treatment with Peg...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen PHASE2 At least 1 dose of pegIFNλ will be identified which is safe, well tolerated...
Show More Location
Advanced Clinical Research Institute
Learn More & Join Trial
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 PHASE2 To evaluate the efficacy of a single dose of subcutaneous injections of 180...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection PHASE1 Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Show More Location
Northwestern Memorial Hospital
Learn More & Join Trial